Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01848756
Title Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Esanex Inc.
Indications

urinary system cancer

Her2-receptor positive breast cancer

esophageal cancer

lung non-small cell carcinoma

Therapies

SNX-5422

Age Groups: adult
Covered Countries USA


No variant requirements are available.